Professor Paul Henri Lambert, Chairman

Professor Lambert is Emeritus professor at the Department of Pathology at the University of Geneva, Switzerland and is involved in its Centre of Vaccinology. He chairs the Steering Committee of the European Research Consortium for new tuberculosis vaccines and directs the International Advanced Course of Vaccinology (ADVAC) organized under the auspices by Fondation Merieux and the University of Geneva.

He was previously at the World Health Organization as head of Immunology Research and Training Program, head of Microbiology and Immunology and latterly head of Vaccine Research and Development for the Global Program of Vaccines and Immunization. Prior to his work at the WHO, he was head of a research unit at the University of Geneva Medical School where he became Professor of the Department of Medicine. He previously worked with Frank Dixon at the Scripps Clinic and Research Foundation, La Jolla, California. He trained as an MD at the University of Liege, Belgium.

He is author or co-author of over 400 publications, a member of several international scientific boards, foreign member of the Royal Academy of Medicine in Belgium and Fellow of the American Association for the Advancement of Science.

Professor Jan Holmgren

Professor Holmgren is Professor of Medical Microbiology and Immunology at Göteborg University, Sweden and Director of the Göteborg University Vaccine Research Institute (GUVAX). He sits on the Board of Directors of the Knut and Alice Wallenberg Foundation (Sweden), the International Vaccine Institute (IVI) and the Global Alliance for Vaccines and Immunization (GAVI). He also chairs or is a member of a number of vaccine-related technical task forces or steering committees and the WHO´s program for new vaccine technologies.

After completing his PhD on urinary tract infection immunology, a large part of his research has focused on the mechanisms of disease and immunity in cholera and other mucosal infections and on the development of mucosal vaccines. He has published more than 500 papers in the fields of microbiology, immunology and vaccinology, received several international awards for his research, and is an elected member of various societies and academies including the Swedish Royal Academy of Science (Medicine) and the Swedish Royal Academy of Engineering (Biotechnology).

Professor Gordon Dougan

Professor Dougan is a Principal Research Scientist and a member of the Board of Management at The Wellcome Trust Sanger Institute in Cambridge, UK. He was previously a Director of the Centre for Molecular Microbiology and Infection at the Imperial College of Science, Technology and Medicine in London and a Professor of Physiological Biochemistry. He is currently a Honorary Professor at Cambridge and Nottingham Universities and a Visiting Professor at the London School of Hygiene and Tropical Medicine. He is a Trustee of the International Vaccine Institute in Korea.

Throughout his career he has served as a Professor, lecturer, referee, advisor, consultant and Board Member for numerous respected institutions, universities, boards, committees, and organisations as well as the MOD in Britain. He worked for over ten years in industry, developing vaccines and novel drugs at an internationally renowned multinational company. He was elected as a Fellow of the Academy of Medical Sciences in 2002.

Professor Charles Waechter

Professor Waechter is Professor of Biochemistry at the University of Kentucky, College of Medicine, Lexington, Kentucky, USA. He is an internationally renowned scientist in the field of glycobiology, establishing the role of lipids in protein glycosylation.

He serves as a Member of the Editorial Board of the Journal of Biological Chemistry and Glycobiology, has authored relevant review articles on glycoconjugates and has published close to 100 original papers in peer reviewed journals.

Professor Armando Parodi

Professor Parodi is an internationally renowned scientist in the field of glycobiology and is Professor of Glycobiology at the Institute Leloir, Buenos Aires, Argentina. He has been a Member of the Advisory Committee on Pathogenesis and Functional Genomics, Special Program for Research and Training in Tropical Diseases, World Health Organization since 1998 and a Foreign Associate of the National Academy of Sciences (USA) since 2000. He was President of the Argentine Society for Research in Biochemistry and Molecular Biology between 1991 and 1993.

During his academic career, he has published over 100 original papers in peer reviewed journals and supervised over 20 PhD students. He serves as a member of the editorial Board of a number of international scientific journals, such as Glycobiology and The Journal of Biological Chemistry.

Dr Ruud Segers

Dr Segers is a molecular bacteriologist with a PhD from the Veterinary Faculty at the State University of Utrecht and is Departmental Head of Bacteriological and Biochemical R&D at its headquarters in Boxmeer, The Netherlands. Since 1991, he has also held various positions at Intervet International (the animal health division of Akzo Nobel) in charge of its research pipeline and development of bacterial vaccines for swine, cattle and horses in Europe.

Dr Segers advises GlycoVaxyn in the development of its pipeline, in the design of animal studies and regulatory issues.